Filter
2527
Filtered Results: 2527
Text search:
drug-resistance
infections
Featured
Recommendations
284
New Publications
656
Language
Document type
No document type
1397
Guidelines
407
Studies & Reports
395
Manuals
117
Strategic & Response Plan
92
Fact sheets
43
Training Material
42
Situation Updates
13
Infographics
10
Brochures
3
Resource Platforms
3
App
2
Online Courses
2
Videos
1
Countries / Regions
India
138
Global
75
South Africa
74
Kenya
71
Western and Central Europe
67
Ethiopia
56
Tanzania
44
Uganda
44
Africa
42
Eastern Europe
42
Nepal
41
Nigeria
37
Zambia
37
Latin America and the Carribbean
33
Namibia
32
Liberia
32
Malawi
30
Sierra Leone
29
Ghana
27
Rwanda
27
Bangladesh
25
Asia
24
Myanmar / Burma
24
Philippines
23
South–East Asia Region
22
Cambodia
20
Zimbabwe
18
Lesotho
17
Ukraine
16
Senegal
15
Russia
15
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
Botswana
10
Albania
8
Burkina Faso
8
West and Central Africa
8
Eswatini/ Swaziland
8
Thailand
7
Haiti
7
East and Southern Africa
7
Pakistan
7
Colombia
6
Syria
6
USA
6
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Argentina
6
China
5
Guinea
5
Georgia
5
Tajikistan
4
Benin
4
Iran
4
Germany
4
Western Pacific Region
4
Vietnam
4
Brazil
4
Sudan
4
North Macedonia
3
El Salvador
3
Laos
3
Peru
3
Jordan
3
North America
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Madagascar
2
Guatemala
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Greece
1
Angola
1
Chad
1
Libya
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
885
Clinical Guidelines
267
Public Health
97
Women & Child Health
77
Key Resources
64
Capacity Building
36
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
TB
447
HIV
332
AMR
318
NTDs
112
Malaria
86
COVID-19
81
Rapid Response
60
Mental Health
56
Pharmacy
53
Caregiver
45
Planetary Health
41
Ebola & Marburg
32
Refugee
27
Global Health Education
27
NCDs
20
Health Financing Toolbox
18
Polio
16
Conflict
13
Cholera
12
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
Antimicrobial resistance (AMR) is an increasing worldwide public health problem with
important implications for the European Union (EU). When antibiotics become
ineffective, bacterial infections lead to increased morbidity, use of healthcare,
mortality and cost. Globally, estimates suggest that ...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions to infection prevention and control practices in o...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
